139 related articles for article (PubMed ID: 6693392)
1. 4-Azasteroidal 5 alpha-reductase inhibitors without affinity for the androgen receptor.
Liang T; Heiss CE; Cheung AH; Reynolds GF; Rasmusson GH
J Biol Chem; 1984 Jan; 259(2):734-9. PubMed ID: 6693392
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of 5 alpha-reductase, receptor binding, and nuclear uptake of androgens in the prostate by a 4-methyl-4-aza-steroid.
Liang T; Heiss CE
J Biol Chem; 1981 Aug; 256(15):7998-8005. PubMed ID: 7263637
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of 5 alpha-reductase activity and alteration of nuclear testosterone. Dihydrotestosterone ratio in human genital skin fibroblasts.
Berkovitz GD; Brown TR; Migeon CJ
J Androl; 1984; 5(3):171-5. PubMed ID: 6746410
[TBL] [Abstract][Full Text] [Related]
4. 12. Androgens: Pharmacodynamics and antagonists. Biochemical and biological studies with 4-aza-steroidal 5 alpha-reductase inhibitors.
Liang T; Rasmusson GH; Brooks JR
J Steroid Biochem; 1983 Jul; 19(1A):385-90. PubMed ID: 6887871
[TBL] [Abstract][Full Text] [Related]
5. Selective inhibition of prostatic tumor 5 alpha-reductase by a 4-methyl-4-azasteroid.
Kadohama N; Karr JP; Murphy GP; Sandberg AA
Cancer Res; 1984 Nov; 44(11):4947-54. PubMed ID: 6488158
[TBL] [Abstract][Full Text] [Related]
6. The effect of a 5 alpha-reductase inhibitor on androgen-mediated growth of the dog prostate.
Wenderoth UK; George FW; Wilson JD
Endocrinology; 1983 Aug; 113(2):569-73. PubMed ID: 6872940
[TBL] [Abstract][Full Text] [Related]
7. Effect of a 4-methyl-4-aza steroid on androgen metabolism by rat ventral prostate epithelial and stromal cell cultures: selective inhibition of 5 alpha-reductase activity.
Orlowski J; Clark AF
Prostate; 1988; 13(4):289-97. PubMed ID: 3217276
[TBL] [Abstract][Full Text] [Related]
8. Species differences in prostatic steroid 5 alpha-reductases of rat, dog, and human.
Liang T; Cascieri MA; Cheung AH; Reynolds GF; Rasmusson GH
Endocrinology; 1985 Aug; 117(2):571-9. PubMed ID: 4017948
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of steroid 5 alpha-reductase from human skin fibroblasts by 17 beta-N,N-diethylcarbamoyl-4-methyl-4-aza-5 alpha-androstan-3-one.
Leshin M; Wilson JD
J Steroid Biochem; 1982 Sep; 17(3):245-50. PubMed ID: 6957692
[TBL] [Abstract][Full Text] [Related]
10. Azasteroids: structure-activity relationships for inhibition of 5 alpha-reductase and of androgen receptor binding.
Rasmusson GH; Reynolds GF; Steinberg NG; Walton E; Patel GF; Liang T; Cascieri MA; Cheung AH; Brooks JR; Berman C
J Med Chem; 1986 Nov; 29(11):2298-315. PubMed ID: 3783591
[TBL] [Abstract][Full Text] [Related]
11. 5 Alpha-reductase inhibitory and anti-androgenic activities of some 4-azasteroids in the rat.
Brooks JR; Berman C; Primka RL; Reynolds GF; Rasmusson GH
Steroids; 1986 Jan; 47(1):1-19. PubMed ID: 3810695
[TBL] [Abstract][Full Text] [Related]
12. Retardation of prostate tumor progression in the Noble rat by 4-methyl-4-aza-steroidal inhibitors of 5 alpha-reductase.
Kadohama N; Wakisaka M; Kim U; Karr JP; Murphy GP; Sandberg AA
J Natl Cancer Inst; 1985 Feb; 74(2):475-86. PubMed ID: 3856054
[TBL] [Abstract][Full Text] [Related]
13. Effect of a new 5 alpha-reductase inhibitor on size, histologic characteristics, and androgen concentrations of the canine prostate.
Brooks JR; Berman D; Glitzer MS; Gordon LR; Primka RL; Reynolds GF; Rasmusson GH
Prostate; 1982; 3(1):35-44. PubMed ID: 7079196
[TBL] [Abstract][Full Text] [Related]
14. Response of rat ventral prostate to a new and novel 5 alpha-reductase inhibitor.
Brooks JR; Baptista EM; Berman C; Ham EA; Hichens M; Johnston DB; Primka RL; Rasmusson GH; Reynolds GF; Schmitt SM; Arth GE
Endocrinology; 1981 Sep; 109(3):830-6. PubMed ID: 7262023
[No Abstract] [Full Text] [Related]
15. Binding of a 4-methyl-4-aza-steroid to 5 alpha-reductase of rat liver and prostate microsomes.
Liang T; Heiss CE; Ostrove S; Rasmusson GH; Cheung A
Endocrinology; 1983 Apr; 112(4):1460-8. PubMed ID: 6832056
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and in vitro activity of 17 beta-(N-alkyl/arylformamido)- and 17 beta-[(N-alkyl/aryl)alkyl/arylamido]-4-methyl-4-aza-3-oxo-5 alpha-androstan-3-ones as inhibitors of human 5 alpha-reductases and antagonists of the androgen receptor.
Li X; Singh SM; Labrie F
J Med Chem; 1995 Mar; 38(7):1158-73. PubMed ID: 7707319
[TBL] [Abstract][Full Text] [Related]
17. Treatment of hirsutism with 5 alpha-reductase inhibitors.
Brooks JR
Clin Endocrinol Metab; 1986 May; 15(2):391-405. PubMed ID: 3521959
[TBL] [Abstract][Full Text] [Related]
18. Photoaffinity labeling of steroid 5 alpha-reductase of rat liver and prostate microsomes.
Liang T; Cheung AH; Reynolds GF; Rasmusson GH
J Biol Chem; 1985 Apr; 260(8):4890-5. PubMed ID: 3988737
[TBL] [Abstract][Full Text] [Related]
19. The effects of diethyl-4-methyl-3-oxo-4-aza-5 alpha-androstane-17 beta-carboxamide (4-MA) and (4R)-5,10-SECO-19-norpregna-4,5-diene-3,10,20-trione (SECO) on androgen biosynthesis in the rat testis and epididymis.
Cooke GM; Robaire B
J Steroid Biochem; 1986 Apr; 24(4):877-86. PubMed ID: 3702462
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the cytosol androgen receptor of the human prostate.
Wilbert DM; Griffin JE; Wilson JD
J Clin Endocrinol Metab; 1983 Jan; 56(1):113-20. PubMed ID: 6183286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
